| |
| |
|
| Insider
Information: |
Keiley Elizabeth M |
| Relationship: |
General Counsel |
| City: |
Abingdon, Oxfordshire |
| State: |
X0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
26,928 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$592,147 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
26,928 |
|
|
| Total
Value |
$592,147 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -32.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oxford Immunotec Global Plc |
OXFD |
SVP & General Counsel |
2019-03-04 |
26,928 |
2015-06-09 |
0 |
Premium* |
|
|
Entasis Therapeutics Holdings Inc. |
ETTX |
General Counsel |
2022-07-11 |
0 |
2021-01-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ETTX |
Entasis Therapeutics Hold... |
General Counsel |
• – – |
2022-07-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(150,000) |
0 |
0 |
- |
|
| ETTX |
Entasis Therapeutics Hold... |
General Counsel |
• – – |
2022-07-07 |
4 |
D |
$2.20 |
$38,658 |
D/D |
(17,572) |
0 |
0 |
- |
|
| ETTX |
Entasis Therapeutics Hold... |
General Counsel |
• – – |
2022-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
167,572 |
0 |
- |
|
| ETTX |
Entasis Therapeutics Hold... |
General Counsel |
• – – |
2021-11-02 |
4 |
D |
$2.94 |
$10,787 |
D/D |
(3,669) |
42,572 |
0 |
- |
|
| ETTX |
Entasis Therapeutics Hold... |
General Counsel |
• – – |
2021-10-19 |
4 |
S |
$3.19 |
$11,991 |
D/D |
(3,759) |
46,241 |
0 |
% |
|
| ETTX |
Entasis Therapeutics Hold... |
General Counsel |
• – – |
2021-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
50,000 |
0 |
- |
|
| ETTX |
Entasis Therapeutics Hold... |
General Counsel |
• – – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| OXFD |
Oxford Immunotec Global P... |
SVP & General Counsel |
• • – |
2019-03-04 |
4 |
AS |
$17.00 |
$69,712 |
D/D |
(4,100) |
26,928 |
0 |
- |
|
| OXFD |
Oxford Immunotec Global P... |
SVP & General Counsel |
• • – |
2019-01-01 |
4 |
D |
$12.78 |
$20,512 |
D/D |
(1,605) |
31,028 |
0 |
- |
|
| OXFD |
Oxford Immunotec Global P... |
SVP & General Counsel |
• • – |
2018-06-13 |
4 |
D |
$14.41 |
$36,025 |
D/D |
(2,500) |
32,633 |
0 |
- |
|
| OXFD |
Oxford Immunotec Global P... |
Senior VP & General Counsel |
• • – |
2018-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,882 |
35,133 |
0 |
- |
|
| OXFD |
Oxford Immunotec Global P... |
Senior VP & General Counsel |
• • – |
2018-01-01 |
4 |
D |
$13.97 |
$15,954 |
D/D |
(1,142) |
24,251 |
0 |
- |
|
| OXFD |
Oxford Immunotec Global P... |
Senior VP & General Counsel |
• • – |
2017-06-15 |
4 |
AS |
$15.01 |
$61,305 |
D/D |
(4,085) |
25,393 |
0 |
- |
|
| OXFD |
Oxford Immunotec Global P... |
Senior VP & General Counsel |
• • – |
2017-06-09 |
4 |
D |
$14.63 |
$16,620 |
D/D |
(1,136) |
29,478 |
0 |
- |
|
| OXFD |
Oxford Immunotec Global P... |
Senior VP & General Counsel |
• • – |
2017-03-20 |
4 |
OE |
$0.81 |
$9,060 |
D/D |
11,185 |
30,614 |
0 |
- |
|
| OXFD |
Oxford Immunotec Global P... |
Senior VP & General Counsel |
• • – |
2017-03-20 |
4 |
AS |
$16.05 |
$48,150 |
D/D |
(3,000) |
22,429 |
0 |
- |
|
| OXFD |
Oxford Immunotec Global P... |
VP & General Counsel |
• • – |
2016-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
7,559 |
16,559 |
0 |
- |
|
| OXFD |
Oxford Immunotec Global P... |
VP & General Counsel |
• • – |
2015-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
9,000 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
